Download Free Medical About Psychopharmacology PowerPoint Presentation

About Psychopharmacology PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : Check out this medical PowerPoint presentation titled "Psychopharmacology".

This medical PowerPoint presentation is about psychopharmacology, the study of how drugs affect the functioning of the brain and behavior. It is a branch of pharmacology that focuses on the use of drugs to treat mental illnesses and psychological disorders. Psychopharmacology aims to identify the mechanisms of action of drugs, their pharmacokinetics (how the body processes the drug), and their effects on the central nervous system.

The use of drugs in psychopharmacology can be classified into several categories, such as antidepressants, anxiolytics, antipsychotics, and mood stabilizers. Antidepressants are used to treat depression, anxiety disorders, and obsessive-compulsive disorder. Anxiolytics are used to treat anxiety disorders and insomnia. Antipsychotics are used to treat schizophrenia, bipolar disorder, and other psychotic disorders. Mood stabilizers are used to treat bipolar disorder.

The development of psychopharmacology has led to significant advancements in the treatment of mental illness. However, it is important to note that psychopharmacological treatments are not a one-size-fits-all solution and can have potential side effects. Therefore, the use of these drugs should be carefully monitored and individualized based on the patients needs and response to treatment.

Tags : Psychopharmacology, mental illnesses, psychological disorders, pharmacokinetics, central nervous system, antidepressants, anxiolytics, antipsychotics, mood stabilizers, pharmaceuticals, pharmaceuticals PowerPoint presentations

Published on : Jun 23, 2023 | Views : 1470 | Downloads : 1

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

1 Chapter 4 Psychopharmacology This multimedia product and its contents are protected under copyright law. The following are prohibited by law: any public performance or display, including transmission of any image over a network preparation of any derivative work, including the extraction, in whole or in part, of any images any rental, lease or lending of the program. 0
Slide 2-

2 Chapter 4 Outline Principles of Psychopharmacology Sites of Drug Action Neurotransmitters and Neuromodulators 0
Slide 3-

3 Principles of Psychopharmacology Psychopharmacology The study of _____________________________________________. Drug effects The changes a drug produces in an animal’s physiological processes and behavior. Sites of _______________ The locations at which molecules of drugs interact with molecules located on or in cells of the body, thus affecting some biochemical processes of these cells. 0
Slide 4-

Drug effects example: Effects of opiates (_______________________) decrease sensitivity to pain, slow down digestion, relax muscles, constrict pupils, induce euphoria Sites of action – specialized receptors in certain neurons in the CNS. 4
Slide 5-

5 Principles of Psychopharmacology Pharm_______________ (movement of drugs) The process by which drugs are absorbed, distributed within the body, metabolized, and excreted. Once a drug enters the body it begins to be ___________________________________________________________________________________________. 0
Slide 6-

6 Principles of Pharmacology Routes of administration Intravenous (IV) injection Injection of a substance directly into a _____. Usually the fastest route Intraperitoneal (IP) injection The injection of a substance into the _________________________________________________________surrounds the stomach, intestines, liver, and other abdominal organs. Used with small animals. 0
Slide 7-

7 Principles of Pharmacology Routes of administration Intramuscular (IM) injection Injection of a substance into a muscle. Absorbed by _________________that supply the muscle. ______________________ (SC) injection Injection of a substance into the space beneath the skin. (TB test). Oral administration Administration of a substance into the mouth, so it is swallowed. (Some drugs are destroyed by digestive ________________). 0
Slide 8-

8 Principles of Pharmacology Routes of administration ________________administration Administration of a substance by placing it beneath the tongue. (Nitroglycerine for coronary artery dilation). Intrarectal administration Administration of a substance into the rectum. (suppository). Inhalation Administration of a vaporous substance into the lungs. (_________________ effects). 0
Slide 9-

9 Principles of Pharmacology Routes of administration Topical administration Administration of a substance absorbed through the __________. (Nicotine patch). Intracerebral administration (Some drugs cannot cross the _______________________). Administration of a substance directly into the brain. Intracerebroventricular (ICV) administration Administration of a substance into one of the cerebral ventricles. 0
Slide 10-

10 Principles of Pharmacology Drug Effectiveness: lipid soluble drugs _____ the blood/brain barrier, water soluble drugs ________. Dose-response curve Plots the magnitude of the effect of a drug as a function of the amount of the drug administered. Therapeutic index The ratio between the dose that produces the desired effect in 50% of the animals and the dose that produces ________ effects in 50% of the animals. 0
Slide 11-

Most drugs have more than one effect. Opiates reduce pain (1), and also depress heart rate and respiration which can be lethal (2). The therapeutic index differs for different classes of drugs. Barbiturates 2-3. Tranquilizers (100+). 11
Slide 12-

12 Principles of Pharmacology Drug Effectiveness ______________: The readiness with which two molecules join together. High affinity drugs produce effects at low concentrations. Low affinity drugs require high concentrations to have an effect. 0
Slide 13-

13 0
Slide 14-

14 0
Slide 15-

15 0
Slide 16-

16 Principles of Pharmacology Effects of repeated administration ________________ (most common pattern) A decrease in the effectiveness of a drug that is administered repeatedly. __________________ (less common, bee stings) An increase in the effectiveness of a drug that is administered repeatedly. 0
Slide 17-

17 Principles of Pharmacology Effects of repeated administration ________________ symptom The appearance of symptoms opposite to those produced by a drug when the drug is administered repeatedly and then suddenly no longer taken. ____________ An inert substance given to an organism in lieu of a physiologically active drug; used experimentally to control for the effects of mere administration of a drug. 0
Slide 18-

Because drugs may have multiple sites of action, the drug effect at some sites may show tolerance, but at other sites tolerance may not be expressed! Tolerance is the result of the body’s attempt to ______________ for the effects of the drug. (Preserve homeostasis). Barbituates cause sedation, and depress respiration. The sedation effect shows tolerance, the depression of respiration does not! 18
Slide 19-

19 Sites of Drug Action ________________ A drug that opposes or inhibits the effects of a particular neurotransmitter on the postsynaptic cell. _______________ A drug that facilitates the effects of a particular neurotransmitter on the postsynaptic cell. 0
Slide 20-

20 Sites of Drug Action Effects on receptors Direct agonist A drug that binds with and activates a receptor. This drug mimics the effects of a neurotransmitter. ________________blocker A drug that binds with a receptor but does not activate it; prevents the natural ligand from binding with the receptor. 0
Slide 21-

21 Sites of Drug Action Effects on receptors Direct antagonist Synonym for a receptor blocker. Noncompetitive binding Binding of a drug to a site on a receptor; does not interfere with the binding site for the principal ligand. 0
Slide 22-

22 Sites of Drug Action Effects on receptors Indirect antagonist A drug that attaches to a binding site on a receptor and interferes with the action of the receptor; does not interfere with the binding of the ___________________. Indirect agonist A drug that attaches to a binding site on a receptor and facilitates the action of the receptor; does not interfere with the binding site of the principal ligand. 0
Slide 23-

23
Slide 24-

24
Slide 25-

Summary: Drugs can _______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________. 25
Slide 26-

Overview: In the brain most synaptic communication is accomplished by just two neurotransmitters. Glutamate – _______________ GABA – ___________________ Glycerine – inhibitory in spinal cord & lower brain stem. In general the other neurotransmitters serve as _________________and act to activate or inhibit entire circuits. Ach activates learning circuits, but what is learned is transmitted by glutamate and GABA neurons. Norepinephrine – heightens vigilance. Serotonin – suppresses some species-typical behaviors. 26
Slide 27-

27 Neurotransmitters and Neuromodulators Acetylcholine The primary neurotransmitter secreted by the efferent axons of the central nervous system. All muscular movement is accomplished by the release of acetylcholine. Appears to be involved in regulating REM sleep, perceptual learning, and memory. 0
Slide 28-

28 Neurotransmitters and Neuromodulators Acetylcholine Acetyl-CoA A cofactor that supplies acetate for the synthesis of acetylecholine. Choline acetyltransferase (ChAT) The enzyme that transfers the acetate ion from acetyl coenzyme A to choline, producing the neurotransmitter acetylcholine. 0
Slide 29-

29
Slide 30-

30
Slide 31-

31 Neurotransmitters and Neuromodulators Acetylcholine Botulinum toxin An acetylcholine antagonist; prevents release by terminal buttons. Black widow spider venom A poison produced by the black widow spider that triggers the release of acetylcholine. Neostigmine A drug that inhibits the activity of acetylcholinesterase. 0
Slide 32-

32 Neurotransmitters and Neuromodulators Acetylcholine (two receptors) _______________receptor An ionotropic acetylcholine receptor that is stimulated by nicotine and blocked by curare. (Rapid action, used at neuromuscular junction). ____________________receptor A metabotropic acetylcholine receptor that is stimulated by muscarine and blocked by atropine. (Second messenger results in slower and more prolonger action. This is the main receptor in CNS.) 0
Slide 33-

33 Neurotransmitters and Neuromodulators Acetylcholine ______________ A drug that blocks muscarinic acetylcholine receptors. A belladonna alkaloid extracted from nightshade. This drug was used to increase _______________. Curare A drug that blocks nicotinic acetylcholine receptors and causes paralysis. In surgery a anesthetic must also be used, because the person is _________________________________, even though they are paralyzed. 0
Slide 34-

34 Neurotransmitters and Neuromodulators Monoamines ______________ Dopamine (DA) Norepinephrine (NE) Epinephrine Indolamines Serotonin (5-HT) 0
Slide 35-

35
Slide 36-

36 Neurotransmitters and Neuromodulators _________________ A class of amines that includes indolamines such as serotonin and catecholamines such as dopamine, norepinephrine, and epinephrine. 0
Slide 37-

37 Neurotransmitters and Neuromodulators Monoamines __________________ A neurotransmitter; one of the catecholamines. Produces both excitatory and inhibitory postsynaptic potentials. Implicated roles in movement, attention, learning, reinforcing effects of abused drugs. Synthesized from tyrosine that we obtain from our diet. 0
Slide 38-

38 Neurotransmitters and Neuromodulators Monoamines-dopamine L-Dopa The biologically active form of DOPA; the precursor of the catecholamines; often used to treat Parkinson’s disease because of its role as a dopamine agonist. Side-effect is heightened_______________. 0
Slide 39-

39 Neurotransmitters and Neuromodulators Monoamines-dopamine ___________________ system A system of neurons originating in the substantia nigra and terminating in the neostriatum (caudate nucleus and putamen of the basal ganglia); appears to play a role in the control of ______________. 0
Slide 40-

40 Neurotransmitters and Neuromodulators Monoamines-dopamine __________________system A system of dopaminergic neurons originating in the ventral tegmental area and terminating in the nucleus accumbens, amygdala, and hippocampus; appears to play a role in the ___________________of drugs that are commonly abused. 0
Slide 41-

41 Neurotransmitters and Neuromodulators Monoamines-dopamine _______________ system A system of dopaminergic neurons originating in the ventral tegmental area and terminating in the prefrontal cortex; appears to influence formation of short-term memories, ___________________________________________. 0
Slide 42-

42 Neurotransmitters and Neuromodulators Monoamines-dopamine ________________ disease A neurological disease characterized by tremors, rigidity of the limbs, poor balance, and difficulty initiating movements; caused by degeneration of the nigrostriatal system; Parkinson’s disease has been treated with L-DOPA. 0
Slide 43-

43 Neurotransmitters and Neuromodulators Monoamines-dopamine AMPT A drug that blocks the activity of tyrosine hydroxylase and thus interferes with the synthesis of the catecholamines. _________________ A drug that interferes with the storage of monoamines in synaptic vesicles; serves as a monoamine antagonist. 0
Slide 44-

44 Neurotransmitters and Neuromodulators Monoamines-dopamine Methylphenidate A drug that inhibits the reuptake of dopamine; also known as ____________; used to treat children with attention deficit disorder. 0
Slide 45-

45 Neurotransmitters and Neuromodulators Monoamines-dopamine _________________________ (MAO) A class of enzymes that destroy the monoamines; dopamine, norepinephrine, and serotonin. deprenyl A drug that blocks the activity of MAO-B; acts as a dopamine agonist. 0
Slide 46-

46
Slide 47-

47 Neurotransmitters and Neuromodulators Monoamines-dopamine _____________________ A drug that reduces the symptoms of schizophrenia by blocking dopamine D2 receptors. 0
Slide 48-

48 Neurotransmitters and Neuromodulators Monoamines-norepinephrine (NE) _________________________ One of the catecholamines; a neurotransmitter found in the brain and in the sympathetic division of the autonomic nervous system. Epinephrine One of the catecholamines; a hormone secreted by the adrenal medulla; serves as a neurotransmitter in the brain. The same molecule can be used as both a hormone and neurotransmitter. 0
Slide 49-

49 Neurotransmitters and Neuromodulators Monoamines-norepinephrine (NE) Norepinephrine is synonymous with nor______________. Found in neurons of the brain and the autonomic nervous system. Almost every region of the brain receives input from noradrenergic neurons. Implicated to play central role in _______________________________________________. 0
Slide 50-

50 Neurotransmitters and Neuromodulators Monoamines-norepinephrine (NE) Fusaric acid A drug that inhibits the activity of the enzyme dopamine-ß-hydroxylase and thus blocks the production of norepinephrine. ____________ would be secreted as a result. Locus coeruleus A dark-colored group of noradreneric cell bodies located in the pons near the rostral end of the floor of the fourth ventricle. 0
Slide 51-

51 Neurotransmitters and Neuromodulators Monoamines-norepinephrine (NE) Axonal varicosity An enlarged region along the length of an axon that contains synaptic vesicles and releases a neurotransmitter or neuromodulator. Idazoxan A drug that blocks presynaptic noradrenergic 2 receptors and hence acts as an agonist, stimulating the synthesis and release of NE. 0
Slide 52-

52 Neurotransmitters and Neuromodulators Monoamines _______________ Serotonin is an indolamine neurotransmitter. Also called 5-HT or 5-hydroxytryptamine. Thought to play a role in the regulation of _________, the control of eating, sleep, dreaming, and arousal. Also thought to be involved in the regulation of pain. The amino acid tryptophan is the precursor of serotonin. 0
Slide 53-

53
Slide 54-

54 Neurotransmitters and Neuromodulators Monoamines-serotonin (5-HT) PCPA A drug that inhibits the activity of tryptophan hydroxylase and thus interferes with the synthesis of 5-HT and serves as a serotonergic antagonist. Fluoxetine (Prozac) A drug that inhibits the reuptake of 5-HT. Used to treat depression, obsessive-compulsive disorder and some anxiety disorders. There are at least ________________ serotonin receptors. Different drugs may selectively effect different receptors. 0
Slide 55-

55 Neurotransmitters and Neuromodulators Monoamines-serotonin (5-HT) Fenfluramine A drug that stimulates the release of 5-HT. __________ A drug that stimulates 5-HT2A receptors. 0
Slide 56-

56 Neurotransmitters and Neuromodulators Monoamines- MDMA A drug that serves as a noradrenergic and serotonergic agonist, also known as _____________ has excitatory and hallucinogenic effects. MDMA damages serotonin pathways. 0
Slide 57-

57 Neurotransmitters and Neuromodulators Amino acids The most common amino acid transmitters are: Glutamate Gamma-aminobutyric acid (GABA) Glycine 0
Slide 58-

58 Neurotransmitters and Neuromodulators Monoamines-glutamate _______________ An amino acid; the most important excitatory neurotransmitter in the brain. NMDA receptor A specialized ionotropic glutamate receptor that controls a calcium channel that is normally blocked by Mg2+ ions; has several other binding sites. AMPA receptor An ionotrpoic glutame receptor that controls a sodium channel; stimulated by AMPA. 0
Slide 59-

Glutamate receptors: Three types of iontropic glutamate receptors. Seven subtypes of metabotropic glutamate receptors. 59
Slide 60-

60
Slide 61-

61 Neurotransmitters and Neuromodulators Amino acids—glutamate Kainate receptor An ionotropic glutamate receptor that controls a sodium channel; stimulated by kainic acid. Metabotropic glutamate receptor A category of metabotropic receptors sensitive to glutamate. 0
Slide 62-

62 Neurotransmitters and Neuromodulators Amino acids—glutamate AP5 A drug that blocks the glutamate binding site on NMDA receptors and impairs certain forms of learning. PCP (Phencyclidine) A drug that binds with the PCP binding site of the NMDA receptor and serves as an indirect antagonist of glutamate. 0
Slide 63-

63 Neurotransmitters and Neuromodulators Amino acids GABA Gamma-aminobutyric acid is an amino acid. GABA is the most important ______________ neurotransmitter in the brain and spinal cord. Allyglycine A drug that inhibits the activity of GAD and thus blocks the synthesis of GABA. 0
Slide 64-

64 Neurotransmitters and Neuromodulators Amino acids—GABA ______________ A direct agonist for the GABA binding site on the GABAA receptor. Bicuculline A direct antagonist for the GABA binding site on the GABAA receptor. 0
Slide 65-

65
Slide 66-

66 Neurotransmitters and Neuromodulators Amino acids—GABA ___________________ A category of anxiolytic drugs; an indirect agonist for the GABAA receptor; these drugs are used for their tranquilizing effects. Examples of these drugs include Valium (diazepam) and Librium (chlordiazepoxide). ___________________ An anxiety-reducing effect. 0
Slide 67-

The brain does not produce valium, barbituates, or picrotoxin. What are the natural ligands for these binding sites? Research has not answered this question. It is assumed that these binding sites are not an accident, and that brain chemicals use them, but they have not yet been identified. 67
Slide 68-

68
Slide 69-

69 Neurotransmitters and Neuromodulators Amino acids ______________ It appears to be the most important inhibitory neurotransmitter in the lower brain stem and spinal cord. Strychnine A direct antagonist for the glycine receptor. Causes convulsions and death even in small doses. 0
Slide 70-

70 Neurotransmitters and Neuromodulators Peptides (Two or more amino acids linked together by peptide bonds) Neurons of the central nervous system release a large variety of peptides. A neuron manufactures both the polypeptides and the enzymes that it needs to break them apart. 0
Slide 71-

71 Neurotransmitters and Neuromodulators Peptides Synthesis takes place in the soma. They are delivered to the terminal buttons by axoplasmic transport. Most peptides appear to serve as ______________, while some act as neurotransmitters. 0
Slide 72-

72 Neurotransmitters and Neuromodulators Peptides __________________opioid A class of peptides secreted by the brain that act as opiates; drugs that effect opioid receptors reduce ______. Enkephalin One of the endogenous opioids. At least three different opioid receptors. Naloxone A drug that blocks opioid receptors; often used to treat heroin overdose.
Slide 73-

73 Neurotransmitters and Neuromodulators Lipids Endocannabinoid A lipid; an endogenous ligand for receptors that bind with ______, the active ingredient of marijuana. Anandamide The first cannabinoid to be discovered and probably the most important one.
Slide 74-

74 Neurotransmitters and Neuromodulators Lipids Rimonabant A drug that blocks cannabinoid CB1 receptors. THC produces analgesia, sedation, reduces nausea, stimulates appetite, but impairs concentration and memory. May distort time perception and change sensory perception. THC can be ____________________________________________________________, the THC is _________________into the CNS.
Slide 75-

75
Slide 76-

76 Neurotransmitters and Neuromodulators Nucleosides Adenosine A combination of ribose and adenine. Released by glial cells and neurons. Dilates blood vessels and increases supply of cellular nutrients. ________________ A bitter-tasting alkaloid drug that blocks adenosine receptors. Adenosine tends to suppress neural activity, and caffeine counters this suppression.
Slide 77-

77 Neurotransmitters and Neuromodulators Soluble gases _________________ (NO) A gas produced by cells in the nervous system; used as a means of communication between cells. Influences blood vessel dilation, and may play a role in sexual arousal. Nitric oxide synthase The enzyme responsible for production of nitric oxide.